Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang
Yin-Chen-Hao-Tang (YCHT) is a famous Chinese medicine formula which has long been used in clinical practice for treating various liver diseases, such as liver fibrosis. However, to date, the mechanism for its anti-fibrotic effects remains unclear. In this paper, an ultra-performance liquid chromatography-time-of-flight mass spectrometry (UPLC-TOF-MS)-based metabolomic study was performed to characterize dimethylnitrosamine (DMN)-induced liver fibrosis in rats and evaluate the therapeutic effects of YCHT. Partial least squares-discriminant analysis (PLS-DA) showed that the model group was well separated from the control group, whereas the YCHT-treated group exhibited a tendency to restore to the controls. Seven significantly changed fibrosis-related metabolites, including unsaturated fatty acids and lysophosphatidylcholines (Lyso-PCs), were identified. Moreover, statistical analysis demonstrated that YCHT treatment could reverse the levels of most metabolites close to the normal levels. These results, along with histological and biochemical examinations, indicate that YCHT has anti-fibrotic effects, which may be due to the suppression of oxidative stress and resulting lipid peroxidation involved in hepatic fibrogenesis. This study offers new opportunities to improve our understanding of liver fibrosis and the anti-fibrotic mechanisms of YCHT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Molecules (Basel, Switzerland) - 21(2016), 1 vom: 21. Jan., Seite E126 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Hongyang [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.10.2016 Date Revised 25.02.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/molecules21010126 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM256791953 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM256791953 | ||
003 | DE-627 | ||
005 | 20231224181427.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/molecules21010126 |2 doi | |
028 | 5 | 2 | |a pubmed24n0856.xml |
035 | |a (DE-627)NLM256791953 | ||
035 | |a (NLM)26805802 | ||
035 | |a (PII)E126 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Hongyang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.10.2016 | ||
500 | |a Date Revised 25.02.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Yin-Chen-Hao-Tang (YCHT) is a famous Chinese medicine formula which has long been used in clinical practice for treating various liver diseases, such as liver fibrosis. However, to date, the mechanism for its anti-fibrotic effects remains unclear. In this paper, an ultra-performance liquid chromatography-time-of-flight mass spectrometry (UPLC-TOF-MS)-based metabolomic study was performed to characterize dimethylnitrosamine (DMN)-induced liver fibrosis in rats and evaluate the therapeutic effects of YCHT. Partial least squares-discriminant analysis (PLS-DA) showed that the model group was well separated from the control group, whereas the YCHT-treated group exhibited a tendency to restore to the controls. Seven significantly changed fibrosis-related metabolites, including unsaturated fatty acids and lysophosphatidylcholines (Lyso-PCs), were identified. Moreover, statistical analysis demonstrated that YCHT treatment could reverse the levels of most metabolites close to the normal levels. These results, along with histological and biochemical examinations, indicate that YCHT has anti-fibrotic effects, which may be due to the suppression of oxidative stress and resulting lipid peroxidation involved in hepatic fibrogenesis. This study offers new opportunities to improve our understanding of liver fibrosis and the anti-fibrotic mechanisms of YCHT | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Yin-Chen-Hao-Tang | |
650 | 4 | |a anti-fibrotic effects | |
650 | 4 | |a lipid peroxidation | |
650 | 4 | |a liver fibrosis | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a partial least squares-discriminant analysis | |
650 | 4 | |a serum metabolomics | |
650 | 4 | |a ultra-performance liquid chromatography-time-of-flight mass spectrometry | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
650 | 7 | |a yin-chen-hao-tang |2 NLM | |
700 | 1 | |a Wang, Xiaoning |e verfasserin |4 aut | |
700 | 1 | |a Hu, Ping |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Wenjun |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Min |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jia |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yuerong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Ping |e verfasserin |4 aut | |
700 | 1 | |a Luo, Guoan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecules (Basel, Switzerland) |d 2004 |g 21(2016), 1 vom: 21. Jan., Seite E126 |w (DE-627)NLM172073448 |x 1420-3049 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2016 |g number:1 |g day:21 |g month:01 |g pages:E126 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/molecules21010126 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2016 |e 1 |b 21 |c 01 |h E126 |